Global Advanced Glycation End Products Market, by Type (Non-fluorescent AGEs, Fluorescent AGEs) by Application (Diabetic Complications, Cancer, Bone Diseases, Neurodegenerative Diseases, Other Applications), By End-Use (Hospitals, Specialty Clinics, Other End-Uses), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Advanced Glycation End Products Market Overview

The global advanced glycation end products market is projected to reach USD 2,760.00 Mn by 2031 at a CAGR of 5.40%, from USD 1,631.18 Mn in 2021.

Global Advanced Glycation End Products Market, by Type (Non-fluorescent AGEs, Fluorescent AGEs) by Application (Diabetic Complications, Cancer, Bone Diseases, Neurodegenerative Diseases, Other Applications), By End-Use (Hospitals, Specialty Clinics, Other End-Uses), and by Region – Global Forecast to 2031”. This report offers a holistic view of the global advanced glycation end products market through systematic segmentation that encompasses every aspect of this target market.

Advanced Glycation End Products (AGEs) are a group of compounds that are formed when sugar molecules attach to proteins. These harmful byproducts can cause inflammation and health problems, including diabetes, heart disease, and Alzheimer’s. While the body produces some AGEs as part of its natural aging process, most of it comes from the food we consume. AGEs are toxins formed when sugar molecules bind to proteins in the body. This process is called glycation—AGEs damage cells and tissues, leading to inflammation, oxidative stress, and other health problems. AGEs can be found in foods such as processed meats, cheese, and baked goods. They are also formed when foods are cooked at high temperatures.

Advanced Glycation End Products, or AGEs, are a type of molecule that forms when food proteins are cooked with sugar. AGEs have been linked to several health problems, including diabetes, heart disease, and Alzheimer’s. There is no known cure for the damage done by AGEs, but there are ways to reduce exposure to them. One way to minimize exposure is to eat fewer cooked foods and rawer foods. As individuals age, cells produce Advanced Glycation End Products (AGEs). AGEs are a type of protein that can damage the body’s tissues and organs. AGEs are linked to many age-related health conditions, including heart disease, diabetes, and Alzheimer’s. There is no cure for the damage caused by AGEs, but there are ways to reduce their impact. Some foods can help protect against the harmful effects of AGEs.

The Global Advanced Glycation End Products Market Revenue (US$ Mn), 2021–2031

Source: Prudour, 2021

Diabetes is linked to an increase in overweight and obese people. As a result, players in the advanced glycation end products market promote HbA1c as a critical component of long-term glycemic control and a reliable biomarker for diabetes diagnosis. The increasing number of cancer cases around the world is likely to fuel market growth since AGEs considerably raise the degree of inflammation in the body, which has long been linked to cancer development. According to the National Cancer Institute, 16.8 million new instances of cancer were diagnosed in the United States in 2016, with 595,690 deaths from the disease. By 2024, the number of cancer patients in the United States is projected to be 19 million. Similarly, the American Cancer Society estimates that 4.3 million new cancer diagnoses and over 2.8 million cancer deaths occurred in China in 2015, with lung cancer being the most prevalent and leading cause of death. These are certain factors that are anticipated to help further augment this market in the years to come.

Over the projected timeline, this market’s economic growth is expected to be hampered by the high cost of cosmetic operations. According to the American Society of Plastic Surgeons, the average cost of botox treatment in the United States is US$ 397, while a single session of microdermabrasion costs around US$ 131, and a chemical peel costs around US$ 669.

The coronavirus infection involving the lungs is linked to a high morbidity and mortality rate. Because the RAGE (Receptor For The Advanced Glycation End Product) pathway is one of the most critical factors of physiological aging, healthcare companies are expanding their range of offered therapy alternatives. The RAGE pathway is thought to play a role in physiological aging and the development of lung illnesses. Stakeholders in the advanced glycation end products market are indexing increased revenues. Additionally, alcohol is one of the most addictive substances on the planet, with billions of people abusing it, resulting in various ailments and injuries. However, there is a scarcity of studies on the molecular pathways that induce cellular toxicity and organ damage due to alcohol abuse. As a result, players in the advanced glycation end products market are beefing up their research & development efforts to establish the biological link between AGE-alcohol adduct production and alcohol-mediated tissue harm. These factors are expected to create lucrative opportunities for existing and emerging players in this market.

Advanced Glycation Products (AGEs), which are formed when sugars are fixed to proteins, form cross-linkages that permanently impair the elasticity of elastin, which is used in aesthetic operations. The American Society of Plastic Surgeons has advised that all elective or non-essential services be postponed due to the pandemic, resulting in a decrease in the number of aesthetic procedures such as chemical peels, botulinum toxin therapy, dermabrasion, etc., stifling the economic growth of the advanced glycation end products market in the process. According to an article published in the Aesthetic Journal on April 3, 2020, the COVID-19 lockdown in London has caused 81% of clinics to close and 67% to lose revenue. Furthermore, due to the COVID-19 pandemic, specific skincare and cosmetic companies are indexing a subsequent decline in sales. For example, Shiseido Company, a Japanese international personal care company, presented its financial statement for Q1 2020 on May 12, 2020, citing a 14.6% and 19.2% year-over-year net sales decline in American and Asia Pacific operations, respectively.

Advanced Glycation End Products Market Segmentation

Based on Type, Application, End-Use, and Region

Based on Type

• Non-Fluorescent AGEs
• Fluorescent AGEs.

Based on Application

• Diabetic Complications
• Cancer
• Bone Diseases
• Neurodegenerative Diseases
• Other Applications

Based on End-Use

• Hospitals
• Specialty Clinics
• Other End-Uses

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

This research report on the global advanced glycation end products market includes major company profiles such as

• Allergan Plc
• Estée Lauder Companies
• Shiseido Company
• Beiersdorf AG
• L’Oréal S.A
• NuFACE
• Ostium Cosmetics
• PhotoMedex Inc.
• Alma Laser
• Rodan & Fields LLC, among others.

For the Advanced Glycation End Products Market research study, the following years have been considered to estimate the market size: